Drag a card by its title · ⚙ to size, swap or remove

The company

Climb Bio, Inc.

CLYM · Nasdaq

Health CareBiotechnologyNot moving yet

CLYM stood above a rising 150-day average in 49 of the last 52 weekly readings, and has been out of that trend for the last 3 weeks. It is 16.4% below that average now. Biotechnology: 16% of its 561 stocks in an uptrend (−15 points in four weeks); Health Care: 26% (−10 points in four weeks).

SEC filings

Statistics

Rotation: Not moving yet
Weeks in an uptrend: out for 3
Industry in uptrend: 16% -15 in 4 wk
Insider buys, 12 months: $805K
Insider sales, 12 months: $5.3M
Officials’ trades on record: 0
Institutions holding: 107 (+31)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 49 of 52 weeks.

20 Apr – 19 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months4

Sale orders, 12 months6

Buyers · sellers3 · 2

Who	Did	Shares	Traded
Stephen Basil ThomasDirector	sold	100,000at $13.67	15 Sep 2026filed 17 Sep 2026
Aoife BrennanPresident and CEO	sold	30,902at $13.17	29 Jun 2026filed 30 Jun 2026
Stephen Basil ThomasDirector	sold	16,313at $7.01	26 Feb 2026filed 27 Feb 2026
Stephen Basil ThomasDirector	sold	33,687at $7.00	25 Feb 2026filed 27 Feb 2026
Stephen Basil ThomasDirector	sold	10,000at $5.81	13 Feb 2026filed 17 Feb 2026
Stephen Basil ThomasDirector	sold	90,000at $5.23	12 Feb 2026filed 17 Feb 2026
Ra Capital Management, L.p.Director, 10% owner	bought	7,111at $3.50	5 Jan 2026filed 7 Jan 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders107+31 on the quarter

New · exited52 · 22

Reported value$707.8M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
RA CAPITAL MANAGEMENT, L.P.unchanged · filed 14 Aug 2026	11,300,939$147.4M	00.0%
FMR LLCadded · filed 13 Aug 2026	6,790,364$88.5M	+6,783,967+106049.2%
UBS Group AGadded · filed 13 Aug 2026	3,404,866$44.4M	+3,318,921+3861.7%
BRAIDWELL LPadded · filed 14 Aug 2026	2,797,375$36.5M	+1,267,700+82.9%
ADAGE CAPITAL PARTNERS GP, L.L.C.new · filed 14 Aug 2026	2,506,000$32.7M	+2,506,000
BlackRock, Inc.added · filed 7 Aug 2026	2,354,872$30.7M	+1,953,223+486.3%
Cormorant Asset Management, LPnew · filed 14 Aug 2026	2,106,000$27.5M	+2,106,000
FRONTIER CAPITAL MANAGEMENT CO LLCnew · filed 14 Aug 2026	1,939,019$25.3M	+1,939,019
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026	1,698,654$22.2M	+519,995+44.1%
Woodline Partners LPnew · filed 14 Aug 2026	1,582,291$20.6M	+1,582,291